- Home
- LOW vs GILD Comparison
LOW vs GILD Comparison
Compare LOW & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOW
- GILD
- Stock Information
- Founded
- LOW 1946
- GILD 1987
- Country
- LOW United States
- GILD United States
- Employees
- LOW N/A
- GILD N/A
- Industry
- LOW RETAIL: Building Materials
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LOW Consumer Discretionary
- GILD Health Care
- Exchange
- LOW Nasdaq
- GILD Nasdaq
- Market Cap
- LOW 127.8B
- GILD 131.5B
- IPO Year
- LOW N/A
- GILD 1992
- Fundamental
- Price
- LOW $219.00
- GILD $104.54
- Analyst Decision
- LOW Buy
- GILD Buy
- Analyst Count
- LOW 24
- GILD 27
- Target Price
- LOW $279.67
- GILD $105.32
- AVG Volume (30 Days)
- LOW 3.2M
- GILD 10.4M
- Earning Date
- LOW 05-20-2025
- GILD 04-24-2025
- Dividend Yield
- LOW 2.10%
- GILD 3.02%
- EPS Growth
- LOW N/A
- GILD N/A
- EPS
- LOW 12.23
- GILD 0.38
- Revenue
- LOW $83,674,000,000.00
- GILD $28,754,000,000.00
- Revenue This Year
- LOW $1.90
- GILD $1.80
- Revenue Next Year
- LOW $3.60
- GILD $3.83
- P/E Ratio
- LOW $17.91
- GILD $275.11
- Revenue Growth
- LOW N/A
- GILD 6.04
- 52 Week Low
- LOW $206.39
- GILD $62.07
- 52 Week High
- LOW $287.01
- GILD $119.96
- Technical
- Relative Strength Index (RSI)
- LOW 42.69
- GILD 43.51
- Support Level
- LOW $213.30
- GILD $97.32
- Resistance Level
- LOW $225.60
- GILD $107.18
- Average True Range (ATR)
- LOW 8.74
- GILD 3.94
- MACD
- LOW -0.03
- GILD -0.45
- Stochastic Oscillator
- LOW 42.43
- GILD 41.42
About LOW Lowe's Companies Inc.
Lowe's is the second-largest home improvement retailer in the world, operating more than 1,700 stores in the United States, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on U.S. Census data and management's market size estimates.
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).